$400M P&L · 350-Person Org · $700B+ Processed
Chris Wyatt
Co-Founder & COO, Finexio. Former GM, Change Healthcare.
Built and ran payments businesses across US healthcare and B2B fintech. A $400M P&L, a 350-person org, an $8B product built from scratch, and a company scaled from zero.
Plain English: he builds the systems that move money between companies, and he has run them at national scale.
Orchestration wins. Single-rail middleware does not.
Federal Reserve · NACHA · HIMSS · 3 books · Selected advisory
$700B+ cumulative payment volumeCumulative payment volume
Two decades. $700B+ in cumulative payment volume.
$400M
P&L Led
Change Healthcare
350
Person Org
B2B & Patient Payments
$160B
Annual Volume
Change Healthcare
$700B+
Cumulative Volume
Across two decades
$75M
Raised
JPMorgan + institutional
01Career
One playbook. Five operating roles.
Convert EDI chaos (the 1970s file format healthcare still runs on) into structured, automatable settlement. Ran a $400M P&L as General Manager at Change Healthcare, then co-founded Finexio and scaled it to $12B+ in annual payment volume on a multi-bank orchestration platform. An earlier turn of the same playbook ran through WellPoint's $300M acquisition of AIM. Open any role for the detail.
The Playbook
- 01Find the friction in a regulated payment flow.
- 02Build the orchestration layer that abstracts the rail.
- 03Compound until the category bends to you.
2018 – Present
Finexio
Co-Founder, Chief Operating Officer & Board Member
$12B+Annual Volume · Active
Co-founded and scaled a B2B payments network from pre-revenue to $20M ARR and $12B+ in annual payment volume on a multi-bank orchestration platform. Backed by $75M raised from JPMorgan and other institutional investors. Recruited the founding team and executive bench, and set product, partnership, and go-to-market strategy. The platform settles payments around the clock without proportional headcount growth, eliminating manual touchpoints with a unified, deterministic data schema that enforces B2B payment logic across heavily regulated environments. Converting unstructured supplier data into autonomous settlement drove material net-new ARR via channel partnerships.
02The Numbers
National scale. Hard outcomes.
Five operating roles across US healthcare and B2B payments. A $400M P&L and a 350-person org at Change Healthcare, a B2B payments network scaled from zero at Finexio, and one institutional exit, all driven from the same data-infrastructure playbook.
Active · Volume
$12B+
Finexio · Annual payment volume today
Scaled a B2B payments network from a blank page in 2018 to $12B+ in annual payment volume. $20M ARR. Top-ten customer cohort retained, verifiable in the diligence room.
Tenure · Volume
$160B
Change Healthcare · Annual volume during tenure
Directed B2B and Patient Payments across the largest US healthcare clearinghouse. Every remittance flow between payers, providers, and patients ran through the platform.
Operating · 2014–2017
$8B
Change Healthcare · General Manager
Built an $8B virtual card operation from a legacy print-and-mail remittance business, $80M of net-new revenue in 18 months.
Exit · 2007
$300M
WellPoint acquisition of American Imaging Management
Operator pre-acquisition through the 2007 WellPoint deal. Stripped $150M+ in administrative overhead and built the data infrastructure and operating model behind the radiology benefit-management business.
03Advisory
Strategic advisory roles
Active advisory engagements across the healthcare payments, patient financing, and AI-driven revenue cycle ecosystem.
PayZen
2019 – PresentStrategic Advisor · Patient Financing
Advising PayZen on go-to-market and enterprise scaling. PayZen underwrites patient bills with AI so providers get paid up front.
Zelis Payments
2018 – PresentStrategic Advisor · Healthcare Payments
Advising Zelis on which payment products to build as it moves from services revenue to software.
Finalytics
2020 – PresentStrategic Advisor · Revenue Cycle & Banking
Advising on product-market fit and enterprise positioning at the complex intersection of healthcare revenue cycle and banking infrastructure, a structurally underserved market requiring deep domain authority on both sides.
CirraGroup
2015 – PresentStrategic Advisor · Medical Debt Resolution
Guiding product strategy and AI integration to transform adversarial medical debt collection into a resolution-oriented, automated patient experience, converting a historically predatory category into a patient-aligned revenue cycle asset.
04Shelves & Press
Books, working groups, selected commentary
Three books, three industry working groups, selected media on the move from manual back-office finance to autonomous agentic payables.
2026
The Last Invoice: How AI Agents Are Ending the Back Office and What Comes Next
Working groups
Federal Reserve BoardNACHAHIMSSContributor, Federal Reserve Board Payment System Policy Advisory Committee (healthcare remittances). Contributor, NACHA Healthcare Payments Advisory Group. Contributor, HIMSS working groups on healthcare data interoperability and payment standards.
Selected commentary
05Thesis
Prediction · 2030
By 2030, the B2B AP function is one human and one agent.
The agent
Runs settlement. Initiates payment. Reconciles. Handles the 95% of B2B transactions that follow the playbook.
The human
Handles exceptions. Approves the edge cases. Makes the calls a regulator wants a person to make.
The losers are any platform that stops at workflow and never reaches the rail. Orchestration wins. Single-rail middleware does not.
Latest Writing
Long-form on agentic payments
Long-form essays on agentic payments infrastructure. New pieces when the analysis is ready.
Latest take
The People Who Can't Drive
Access to AI has been democratized. The capacity to wield it has not. And the gap is widening faster than any technology gap in human history.
06Pattern Recognition
Eight theses, one pattern
Twenty years inside US healthcare clearinghouses produced the same observation across surface after surface. Canonicalization beats workflow. Two of these are in active discovery. The rest are essays.
07FAQ
Questions recruiters and search committees ask
Straight answers on scope, track record, and the seat that fits. The detail behind each one runs through the career and writing above.
What is Chris Wyatt's biggest operating role?
General Manager of a $400M P&L and a 350-person organization at Change Healthcare, the largest US healthcare clearinghouse, across B2B and Patient Payments. He rebuilt a legacy print-and-mail remittance business into an $8B virtual card operation and drove $80M of net-new revenue in 18 months on $160B in annual payment volume.
What has Chris Wyatt built?
He co-founded Finexio and scaled it from pre-revenue to $20M ARR and $12B+ in annual payment volume on a multi-bank orchestration platform, backed by $75M raised from JPMorgan and other institutional investors. Earlier, he built the $8B virtual card operation at Change Healthcare from scratch.
Has Chris Wyatt had an exit?
Yes. He was an operator at American Imaging Management through WellPoint's $300M acquisition in 2007.
What kind of role is Chris Wyatt looking for?
President, COO, or General Manager roles, and CEO of a company where domain expertise, building from zero, and commercial outcomes decide the seat. He works where healthcare payments, B2B fintech, and payments infrastructure overlap.
What industries and skills does Chris Wyatt know?
US healthcare payments, B2B fintech, payment orchestration, accounts payable automation, and the data infrastructure beneath all of them. Two decades across WellPoint/AIM, UnitedHealth, Change Healthcare, Parasail, and Finexio.
What does Chris Wyatt write and speak about?
Three books on agentic payments (2024 to 2026) and ongoing essays on autonomous settlement and the orchestration layer above bank rails. He contributes to the Federal Reserve Board Payment System Policy Advisory Committee, the NACHA Healthcare Payments Advisory Group, and HIMSS working groups.
A first for an executive search
Do not read my resume. Interrogate it.
An AI agent grounded in my track record answers what a search committee would ask: scope, numbers, exits, how the $8B build actually happened. It refuses what it does not know.
No payments background needed. Ask it anything a board would ask.
- What did he actually own at Change Healthcare?
- Why leave a company he co-founded?
- What is the $700B made of?
Built on the same agentic stack the essays describe.
The essay list
Get new essays in your inbox
Where the autonomous settlement stack is heading, what I am watching, and the calls I am making in public. Every email includes an unsubscribe link.
Prefer LinkedIn? Subscribe to The Long Game. Opens in a new tab.
08Contact
Get in touch
Direct inquiries only. Write something specific and you will hear back.
Recruiters, search firms, and press: I read everything, and relevant notes get a reply.
No marketing or sales pitches.